Smiths Group (SMIN)

Sector:

Manufacturing

Index:

FTSE 100

 1,449.50p
   
  • Change Today:
      0.000p
  • 52 Week High: 1,661.00p
  • 52 Week Low: 1,355.50p
  • Currency: UK Pounds
  • Shares Issued: 395.70m
  • Volume: 0
  • Market Cap: £5,736m
  • RiskGrade: 127
  • Beta: 1.19

Smiths Group agrees $2.4bn sale of med unit to ICU Medical

By Frank Prenesti

Date: Wednesday 08 Sep 2021

LONDON (ShareCast) - (Sharecast News) - Industrial technology group Smiths Group said it agreed to sell is medical business to US-based ICU Medical for $2.4bn, withdrawing its support for a rival $2bn offer from TA Associates agreed last month.
Smiths agreed to sell the division, which makes respiratory devices and catheters, as it shifted focus to its core industrial technology business.

"The ICU Transaction delivers $0.4bn more value to shareholders and carries future material upside through both participation in ICU Medical equity and a $0.1bn 'earnout'. In light of this, the Smiths board has withdrawn its recommendation of the TA Transaction,"v Smiths said in a statement.

Smiths said it was planning to return 55%, equivalent to £737m at current exchange rates, of the initial net cash proceeds to shareholders via a share buyback. The retained net cash proceeds would be used to create "a strong balance sheet" and support investment in growth opportunities.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Smiths Group Market Data

Currency UK Pounds
Share Price 1,449.50p
Change Today 0.000p
% Change 0.00 %
52 Week High 1,661.00p
52 Week Low 1,355.50p
Volume 0
Shares Issued 395.70m
Market Cap £5,736m
Beta 1.19
RiskGrade 127

Smiths Group Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
60.05% below the market average60.05% below the market average60.05% below the market average60.05% below the market average60.05% below the market average
42.86% below the sector average42.86% below the sector average42.86% below the sector average42.86% below the sector average42.86% below the sector average
Price Trend
58.95% below the market average58.95% below the market average58.95% below the market average58.95% below the market average58.95% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Income
19.91% above the market average19.91% above the market average19.91% above the market average19.91% above the market average19.91% above the market average
33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average
Growth
33.33% above the market average33.33% above the market average33.33% above the market average33.33% above the market average33.33% above the market average
42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average

What The Brokers Say

Strong Buy 6
Buy 2
Neutral 0
Sell 1
Strong Sell 0
Total 9
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Smiths Group Dividends

  Latest Previous
  Final Interim
Ex-Div 21-Oct-21 08-Apr-21
Paid 19-Nov-21 14-May-21
Amount 26.00p 11.70p

Trades for --2021

Time Volume / Share Price
0 @ 0.000p

Smiths Group Key Personnel

Chair George Buckley
CFO John Shipsey

Top of Page